In vitro: leukemia—KT-1, lymphoma—U937, myeloma—U266, Akt1/2+/+, Akt1/2−/−, Ulk1/2+/+ & Ulk1/2−/− MEFs. This evidence concerns the gene AKT1 and lymphoma.